Introduction
Despite strenuous opposition, Ilya Metchnikov convinced the scientific world 1 10 years ago that phagocytosis has a major role in immunity to infection (1) .' Metchnikov conjectured that phagocytes destroy microbes with their enzymes, or cytases as he called them, but proof of this had to wait for new tools. The field moved when Cohn and Hirsch (1) revealed the role of degranulation in phagocytosis. Hirsch described phagocytin (1) . Spitznagel and Chi (1) and Zeya and Spitznagel (1) showed that phagocytin is not one but an array ofantibacterial proteins, uniquely cationic, associated with cytoplasmic granules, and coated on bacteria during phagocytosis. Klebanoff described the myeloperoxidase (MPO),2 H202, Cl-antimicrobial system (1), and Gray described the oxidative defect in neutrophils and monocytes of children with X-linked chronic granulomatous disease (2) . The duality of the killing mechanisms, oxygen independent and oxygen dependent, and the association of many of their components with cytoplasmic granules became accepted. I deal here with one aspect of research on oxygen-independent mechanisms, the antibiotic proteins of human neutrophils. These proteins comprise at least three structurally different families that share the capacity to kill bacteria independent of oxygen and evidently, contrary to Metchnikov's conjecture, to do so independent of enzymic action.
Current definition ofantibiotic proteins
Seven proteins associated with the azurophil granules of human neutrophils are currently in center stage owing to their potent antibioticlike actions (see Table I ). In ascending order according to their apparent molecular weights, they are: defensins, HNP-1, HNP-2, and HNP-3,3 HNP-4 (3); cathepsin G (CatG) (1); CAP37/azurocidin (4-6); and BPI/CAP57/BP (1, 4, 7) . That there may be more is reflected in the recent work of Gabay et al. (6) who described HNP-4, a recent addition to the defensins (3), and p29b, a newly described serine proteinase. I shall not deal with lactoferrin or lysozyme because both have been reviewed (1) . The seven proteins will be dealt with in three major groups: defensins, CatG and CAP37/azurocidin, and BPI/CAP57/BP. Differences within groups will probably be resolved in the future or be confirmed and their significance clarified.
Antimicrobial action: range and specific activities Considered as a group, the antibiotic proteins have a wide range, being active against gram positive and gram negative bacteria, viruses, and fungi. Their specific activities vary depending on the protein, the pH, ionic strength, temperature, the presence of nutrients in the test medium, and the species and strain of microbe (1) . Table II shows ranges and approximate activities for the most studied antibiotic proteins (3, 5, 7, 8, 9, 10, 27) . Structure and molecular biology
The human defensins comprise a group of four small, strikingly similar cyclic peptides (see Fig. 1 ). The first three differ only in their NH2-terminal amino residues, appear unglycosylated, and bear strong homology to defensins of other species (I 1). Each has six cysteines, is relatively rich in arginine and aromatic amino acids (3, 27) . Their cyclic structure is unique and depends on disulfide bonds formed between cysteines (1 1). HNP-4 is similar, has a similar arrangement of cysteines as do the other defensins, but only 11 of the 33 amino acid positions are alike (3) . Two crystalline forms of a human defensin, HNP-1, have been reported (12) .
Human defensin cDNA clones show the predicted proteins are produced as 94 residue precursors that are placed in the cell membrane system due to hydrophobic NH2-terminal signal peptides and are eventually processed to the 30-33 residue proteins found in the neutrophil cytoplasmic granules (13) . Interestingly only cDNA coding for HNP-1 and HNP-3 were cloned from the HL60 library used. Thus, HNP-2 may be actually HNP-l or HNP-3 with its NH2-terminal amino acid cleaved off. Normal bone marrow cells, but not peripheral blood cells, expressed defensin mRNA.
Cathespin G (Fig. 2) shows strong homologies with elastase, CAP37/azurocidin, and several inflammatory proteinases. CAP37 and azurocidin are probably identical, although apparent differences in their molecular weights await explanation. CatG cDNA has been cloned (14) and the inferred amino acid sequence shows it is produced as a pre-pro protein.
CAP37/azurocidin has recently been cloned (Morgan, J., personal communication) and shows similar structure suggesting it is produced as a pre-pro protein.
In it the cysteines seen in CatG are conserved as well. CAP37/azurocidin is unusual because, although it has 50% or greater homology with elastase, it fails to perform as a serine proteinase (6, 15) due to replacement of its catalytic His-41 residue (see Fig. 2 ) by a serine residue (15) . Moreover, it contains several constituent peptides not heretofore described in any serine proteinase (Morgan, J., personal communication). The conservation in the neutrophil ofa molecule ofthis family with antibacterial and other properties (see below) yet incapable of serine proteinase activity suggests that it has a unique role in host defense.
A predicted structure of BPI, determined by microsequencing of its NH2-terminal 27 residues and inferred from sequencing of its cDNA (16, 17) , reveals a high proportion of basic and hydrophobic residues among its NH2-terminal 27 amino acids (see Fig. 3 ). Rabbit BPI and rabbit lipopolysaccharide binding protein (LBP), described by Tobias and Ulevitch (18) , share with human BPI substantial homologies and are closely related to each other but not to other known proteins. We have recently sequenced the NH2-terminal residues of CAP57, an antibiotic protein (19) . Its first 27 NH2-terminal residues are identical with those of BPI (see Fig. 3 ). We found that our monoclonal and polyclonal antibodies to CAP57 (20) in Western blots and ELISA were completely reactive with BPI kindly furnished by Randy Scott (Invitron Corp., Redwood City, CA). We believe CAP57 is identical to BPI. BP, reported by Hovde and Gray (7), has an amino acid composition close to that of BPI and its NH2-terminal residues are 100% homologous with those of BPI (Gray, B. H., personal communication).
Ooi et al. (21) have found that antimicrobial capacity of BPI/CAP57/BP is confined to the NH2-terminal 25-kD domain of BPI. That domain is cationic and amphipathic (17) . That antimicrobial action is confined to one domain or structure of BPI/CAP57/BP is further supported by our discovery of a monoclonal antibody, P1G8, that specifically binds and inhibits the antimicrobial action of the protein, whereas another one, P2A5, binds but fails to inhibit (20) . Near the NH2-terminus of CatG, Bangalore et al. (2 la) have identified two small peptides with broad antibacterial action in vitro.
The COOH-terminal nonantibiotic region of BPI/CAP57/ BP appears to be relatively anionic and very hydrophobic and may be an anchor that holds the holo-protein in the membrane of the granule (17 (1, 4, 27) . Bacterial death correlates closely with cytoplasmic membrane damage (27) .
Other actions
So much attention has been focused on the antibiotic properties of the granule proteins that the possibility they serve some other physiological function has remained relatively unexplored. However, a few unexpected, interesting, and possibly 10 20 Holo-BPI (27) , further evidence of their capacity to damage membranes. The enzymic activity of CatG has been recognized (1) for some time and is consistent with its primary serine proteinaselike structure (14) . Although the antimicrobial property of CatG is independent of its enzymic action, its proteolytic action is likely to contribute to digestion of killed microbes. CAP37/azurocidin is a potent chemotactic agent specific for monocytes and may conceivably have a substantial role in the influx of monocytes in inflammation (31) . Its activity is 80-100% that of FMLP (31) . Defensins have been reported to be chemotactic (32) , but at levels 10-20% that of FMLP. BPI/CAP57/BP has been established as a member of a family of proteins that bind lipopolysaccharides (22) . No Human defensins are confined to neutrophils where they comprise 30-50% of the granule proteins (6, 27) and are stored in a heavy subset of the azurophil granules (27) . They are translocated to phagolysosomes during phagocytosis and deposited there through degranulation, achieving high concentrations. < 8% may be released from the cell during phagocytosis (34) . This meager release makes it seem unlikely they exercise an extracellular function. Their optimum antimicrobial activity is said to be pH -7.0, so they probably find a hydrogen ion concentration optimum for their activity, at least in the early phase of phagolysosome formation (1) . CatG may comprise as much as 18% of the azurophil granule membrane protein. It is confined to neutrophils and to the azurophil granules (1, 6) . Consistent with this, CatG appears in the promyelocytes of the bone marrow and is present in myelocytes and other more mature forms (1) . Owing to the segregation of azurophil granules during cell division, the more mature cells contain less CatG than the promyelocytes and myelocytes. Although direct evidence is lacking, it is likely that CatG also enters the phagolysosome during phagocytosis and degranulation, as does myeloperoxidase (1) . Its optimum hydrogen ion concentration for antimicrobial action is broad against gonococci (9) but narrow against S. aureus (1). The pH should be suitable throughout the life of phagolysosomes.
CAP37/azurocidin also is a component of the azurophil granules (5, 35) with a concentration of -11 fg per cell (31) . It is expressed first in promyelocytes. In the mature neutrophil it comprises -17% ofproteins extracted from azurophil granule membranes (6) . Its antimicrobial activity is maximal at pH 5.7, so it may become increasingly active as phagolysosomes mature (1) . 80% or more ofCAP37/azurocidin is released from neutrophils during phagocytosis ( 15 and see above) . Extracellular release of this chemotactic protein may account for the influx of monocytes into inflammatory foci infiltrated by neutrophils ( 15) .
BPI/CAP57/BP is expressed in the neutrophil granulocyte line (17, 19, 36) . It is synthesized and stored in the azurophil granules during the promyelocyte and early myelocyte stages of the neutrophil. In mature neutrophils it comprises 2-4% of the granule proteins. Spitznagel et al. (1) showed with density gradient centrifugation and Rice et al. (27) confirmed that azurophil granules are heterogeneous in density and component proteins. BPI/CAP57/BP is concentrated in the least dense azurophil granules according to Percoll sedimentation ( 19) . The localization of different antibiotic proteins in different subpopulations of granules suggests different pathways, different timing, or both, for packaging in and perhaps for release from granules. BPI/CAP57/BP is only sparingly released from neutrophils during phagocytosis (31, 36) .
Intraphagosomal events
What actually happens in the phagolysosome? The hydrogen ion concentration in the neutrophil phagolysosome drops to low levels concomitant with its formation. It is clear from available publications that the ranges of pH optima determined for the granule proteins fall within even the narrow estimates of phagolysosome pH. Shafer has pointed out that one or another of the contents, including the most powerfully antibacterial ones, would potentially be optimally active at some point in the history of the phagolysosome (5). It is important to note here that several investigators have gone to some trouble to show that oxygen-independent killing actually occurs (1) . Most recently E. coli has been shown to be killed both by anaerobic normal neutrophils and by chronic granulomatous disease (CGD) neutrophils. The question was, and is, what killed them. Stinavage took advantage of a mutant, BPI/ CAP57/BP-resistant S. typhimurium and its isogenic parent to show that the resistant mutant had a clear advantage and survived in larger numbers than the sensitive parent when phagocytized by anaerobic neutrophils (37) . This was even true under aerobic conditions, suggesting that intraneutrophilic Salmonella are largely killed by the oxygen-independent pathways (37, 38) even when oxygen is available. Unfortunately the experiment fails to give the answer as to which antibiotic protein should get the credit because this strain of S. typhimurium is also resistant to CAP37/azurocidin (5) . In any event, cationic antimicrobial proteins of neutrophils seem to have an antibiotic role in the phagolysosome.
Genetics and role in disease It is truly exciting to find we now have knowledge of neutrophil antimicrobial proteins that places us at the threshold of clinical uses. Perhaps the cumulative work reviewed above affords us ways to study the pathophysiology and genetics of disorders of antibiotic proteins as we were afforded ways to study the disorders in oxidative killing by Holmes' discoveries in CGD (39 17 normal volunteers and 33 patients with various diseases, mostly genetically determined disorders involving the neutrophils. These people were screened for neutrophil levels of defensins, CatG, elastase, lactoferrin, and lysozyme. Severely depressed defensin levels were found in neutrophils of two patients with specific granule deficiency (SGD). Unfortunately the pathogenesis and genetics ofSGD are not well defined. The first case of SGD reported was clearly acquired (1) , and that 40-yr-old patient was Philadelphia chromosome positive. Most of the subsequently reported cases were children born of nonconsanguineous unions (39) . In any event, Ganz's results suggest that the vulnerability ofSGD sufferers to infection (39) may be due, at least in part, to defensin deficiency. The molecular genetics of the deficiency were not defined. Nevertheless, the results are stimulating and show the need for far more extensive studies. Studies on patients with disorders of antibiotic proteins will not, however, be straightforward. There is presently no equivalent to the relatively simple screening tests applicable to CGD. Moreover, there are several different antibiotic proteins, each coded by a different gene. As far as is known, the antibiotic proteins act in parallel in vivo and not in series as do the proteins in an interdependent enzyme pathway.
CAP37/azurocidin and BPI/CAP57/BP for example are substantially more potent than the defensins, but the defensins are abundant. Because it is unlikely that mutation would affect all proteins at once, vulnerability to infection may not be a dramatic indicator of deficiency. In Ganz's paper the methodology hinged on complex and expensive technology. In the future, highly specific oligonucleotide probes will be coming on line (13, 14, 17, 41 ) that will find a place in in situ hybridization and other molecular diagnostic techniques. Such approaches have already shown that defensin genes are localized to human chromosome 8p23 (41) . The availability of such techniques will permit highly specific screening in a variety of modalities but the investigations will still be costly.
The three patients with Chediak-Higashi (CH) syndrome had severely depressed elastase and CatG levels (40). as have animals with CH (39) 
